Abstract
No public abstract is available from the verified source records.
Luigi Dall’Olmo, Francesco Callegarin, Francesco Russano, Bianca Finadri, Nicolò Martinelli, Alessandra Buja, Marco Rastrelli, Simone Mocellin
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Human colorectal cancers express a constitutively active cholecystokinin-B/gastrin receptor that stimulates cell growth
10.1074/jbc.m005754200 · 2000
Gastrin and gastric cancer
10.1016/j.jcmgh.2017.03.004 · 2017
Gastrin: from physiology to gastrointestinal malignancies
10.1093/function/zqab062 · 2021
Gastrin stimulates the growth of gastric pit cell precursors by inducing its own receptors
10.1152/ajpgi.00117.2001 · 2002
Promoting role of cholecystokinin 2 receptor (CCK2R) in gastrointestinal stromal tumour pathogenesis
10.1002/path.4071 · 2012
Gastrin receptor pharmacology
10.1007/s11894-012-0293-1 · 2012
Assessment of cholecystokinin 2 receptor (CCK2R) in neoplastic tissue
10.18632/oncotarget.7522 · 2016
Insights into effects/risks of chronic hypergastrinemia and lifelong PPI treatment in man based on studies of patients with Zollinger–Ellison syndrome
10.3390/ijms20205128 · 2019
Gastrin stimulates a cholecystokinin-2-receptor-expressing cardia progenitor cell and promotes progression of Barrett’s-like esophagus
10.18632/oncotarget.10667 · 2017
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
Expression cloning and characterization of the canine parietal cell gastrin receptor
10.1073/pnas.89.8.3605 · 1992
Gastric acid secretion in the totally isolated, vascularly perfused rat stomach. A selective muscarinic-1 agent does, whereas gastrin does not, augment maximal histamine-stimulated acid secretion
10.3109/00365528709011147 · 1987
Gastrin has a specific proliferative effect on the rat enterochromaffin-like cell, but not on the parietal cell: a study by elutriation centrifugation
10.1046/j.1365-201x.2000.00688.x · 2000
Perspectives on gastric cancer: the central role of gastrin in carcinogenesis by Helicobacter pylori, oxyntic atrophy and drug-induced acid suppression
10.3389/fonc.2026.1807681 · 2026
Pathophysiology of gastric NETs: role of gastrin and menin
10.1007/s11894-017-0572-y · 2017
Exploiting cancer’s phenotypic guise against itself: targeting ectopically expressed peptide G-protein coupled receptors for lung cancer therapy
10.18632/oncotarget.18403 · 2017
Proton pump inhibitors and risk of gastric cancer: a population-based cohort study
10.1038/sj.bjc.6605024 · 2009
Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology
10.1111/apt.13324 · 2015
Zinc ions mediate gastrin expression, proliferation, and migration downstream of the cholecystokinin-2 receptor
10.1210/en.2016-1270 · 2016
Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population-based study
10.1136/gutjnl-2017-314605 · 2018
Unresolved referenced work
Kept as external metadata until matched
Expression of the cholecystokinin-B receptor in neoplastic gastric cells
10.1007/s12672-017-0311-8 · 2018
Types of gastric carcinomas
10.3390/ijms19124109 · 2018
Correct identification of cell of origin may explain many aspects of cancer: the role of neuroendocrine cells as exemplified from the stomach
10.3390/ijms21165751 · 2020
CCK2R antagonists: from SAR to clinical trials
10.1016/j.drudis.2020.05.008 · 2020
Cholecystokinin-2 receptor targeting with radiolabeled peptides: current status and future directions
10.2174/0929867327666200625143035 · 2020
Update on preclinical development and clinical translation of cholecystokinin-2 receptor targeting radiopharmaceuticals
10.3390/cancers13225776 · 2021
Utilizing peptide ligand GPCRs to image and treat pancreatic cancer
10.3390/biomedicines6020065 · 2018
Theranostic prospects of gastrin-releasing peptide receptor–radioantagonists in oncology
10.1016/j.cpet.2017.02.007 · 2017
Novel insight on GRP/GRPR axis in diseases
10.1016/j.biopha.2023.114497 · 2023
Progastrin-releasing peptide as a diagnostic biomarker of pulmonary and non-pulmonary neuroendocrine neoplasms
10.1080/07435800.2024.2365895 · 2024
Gastrin-releasing peptide receptor (GRPR) as a novel biomarker and therapeutic target in prostate cancer
2024
Gastrin releasing peptide receptors-targeted PET diagnostics and radionuclide therapy for prostate cancer management
10.1016/j.cpet.2024.03.004 · 2024
CCK2R identifies and regulates gastric antral stem cell states and carcinogenesis
10.1136/gutjnl-2014-307190 · 2015
Progastrin: an overview of its crucial role in the tumorigenesis of gastrointestinal cancers
10.3390/biomedicines12040885 · 2024
Gastrin and upper GI cancers
10.1016/j.coph.2016.08.013 · 2016
Structure of a human gastrin gene
10.1073/pnas.81.4.1067 · 1984
Structural analysis of the gene encoding human gastrin: the large intron contains an Alu sequence
10.1073/pnas.81.15.4662 · 1984
Gastrin, cholecystokinin, signaling, and biological activities in cellular processes
10.3389/fendo.2020.00112 · 2020
Pathways of processing of the gastrin precursor in rat antral mucosa
10.1172/jci117839 · 1995
The new biology of gastrointestinal hormones
10.1152/physrev.1998.78.4.1087 · 1998
Emerging PET imaging agents and targeted radioligand therapy: a review of clinical applications and trials
10.3390/tomography11080083 · doi-reference
Transformation to neuroendocrine phenotype in non-small-cell lung carcinoma: a literature review
10.3390/ijms26115096 · doi-reference
Comparative in vitro and in vivo evaluation of two 64Cu-labeled bombesin analogs in a mouse model of human prostate adenocarcinoma
10.1016/j.nucmedbio.2005.12.011 · doi-reference
Localization of 99mTc-GRP analogs in GRPR-expressing tumors: effects of peptide length and neprilysin inhibition on biological responses
10.3390/ph12010042 · doi-reference
Radiolabeled bombesin derivatives for preclinical oncological imaging
10.1016/j.biopha.2016.12.083 · doi-reference
GRPR expression in metastatic cancers: a review of potential application of GRPR-radioligand therapy
10.1053/j.semnuclmed.2025.07.003 · doi-reference
Gastrin-releasing peptide receptor as a theranostic target in breast cancer: a systematic scoping review
10.1053/j.semnuclmed.2024.01.004 · doi-reference
Molecular targets and the emerging role of copper radionuclides in prostate cancer theranostics
10.1186/s13550-025-01325-4 · doi-reference
GRPR-targeting radiotheranostics for breast cancer management
10.3389/fmed.2023.1250799 · doi-reference
Molecular imaging of prostate cancer
10.1148/rg.2016150059 · doi-reference
Potential targets other than PSMA for prostate cancer theranostics: a systematic review
10.3390/jcm10214909 · doi-reference
Current status of radiopharmaceuticals for the theranostics of neuroendocrine neoplasms
10.3390/ph10010030 · doi-reference
Pro-gastrin-releasing peptide (ProGRP) as a biomarker in small-cell lung cancer diagnosis, monitoring and evaluation of treatment response
10.2147/lctt.s149516 · doi-reference
Biochemical markers for neuroendocrine tumors: traditional circulating markers and recent development—a comprehensive review
10.3390/diagnostics14121289 · doi-reference
Non-invasive markers for the detection of gastric precancerous conditions
10.3390/cancers16122254 · doi-reference
The role of gastric microbiota in gastric cancer
10.1080/19490976.2020.1762520 · doi-reference
Problems associated with deprescribing of proton pump inhibitors
10.3390/ijms20215469 · doi-reference
Side effects of long-term proton pump inhibitor use: a review
10.1111/bcpt.13023 · doi-reference
Long term use of proton pump inhibitors and risk of stomach cancer: population based case-control study in five Nordic countries
10.1136/bmj-2025-086384 · doi-reference
Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy
10.1007/s00535-022-01930-3 · doi-reference
Proton pump inhibitors and cancer: current state of play
10.3389/fphar.2022.798272 · doi-reference
Gastrin and gastric cancer
10.3389/fendo.2017.00001 · doi-reference
Endoscopic findings and outcomes of gastric mucosal changes relating to potassium-competitive acid blocker and proton pump inhibitor therapy
10.1002/deo2.400 · doi-reference
Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden
10.1136/bmjopen-2017-017739 · doi-reference
Bombesin-targeted PET of prostate cancer
10.2967/jnumed.115.170977 · doi-reference
Prostate cancer theranostics targeting gastrin-releasing peptide receptors
10.1007/s11307-017-1151-1 · doi-reference
The human gastrin-releasing peptide receptor gene structure, its tissue expression and promoter
10.1016/s0378-1119(00)00596-5 · doi-reference
Advantages and disadvantages of long-term proton pump inhibitor use
10.5056/jnm18001 · doi-reference
Annexin II binds progastrin and gastrin-like peptides, and mediates growth factor effects of autocrine and exogenous gastrins on colon cancer and intestinal epithelial cells
10.1038/sj.onc.1209798 · doi-reference
Gastrin and gastrin receptor antagonists bind to both N- and C-terminal halves of the 78 kDa gastrin-binding protein
10.1016/s1357-2725(96)00066-0 · doi-reference
Novel gastrin receptors mediate mitogenic effects of gastrin and processing intermediates of gastrin on Swiss 3T3 fibroblasts: absence of detectable cholecystokinin (CCK)-A and CCK-B receptors *
10.1074/jbc.270.15.8429 · doi-reference
Helicobacter pylori extract induces nuclear factor-kappa B, activator protein-1, and cyclooxygenase-2 in esophageal epithelial cells
10.1016/j.gassur.2005.09.003 · doi-reference
Gastrin induces proliferation in Barrett’s metaplasia through activation of the CCK2 receptor
10.1053/gast.2003.50091 · doi-reference
Management of gastric neuroendocrine tumors: a review
10.1245/s10434-023-14712-9 · doi-reference
Neuroendocrine neoplasms of the stomach. Update on diagnostic criteria, classification, and prognostic markers
10.1007/s00428-025-04340-x · doi-reference
Gastrointestinal neuroendocrine tumors in 2020
10.4251/wjgo.v12.i8.791 · doi-reference
Helicobacter pylori and gastric acid: an intimate and reciprocal relationship
10.1177/1756283x16663395 · doi-reference
The central role of gastrin in Helicobacter pylori gastric carcinogenesis
10.1080/00365521.2025.2509094 · doi-reference
Tumor microenvironment in gastric cancers
10.1111/cas.14521 · doi-reference
Hormonal suppression of stem cells inhibits symmetric cell division and gastric tumorigenesis
10.1016/j.stem.2020.01.020 · doi-reference